What factors are contributing to the unexpected 30% increase in production costs for Solugen's BioPeroxide in the last month?

Introduction

The unexpected 30% increase in production costs for Solugen's BioPeroxide over the last month is a critical issue that demands immediate attention. This analysis will systematically identify, validate, and address the root cause while considering both short-term and long-term implications for the product and company.

I'll approach this problem by first clarifying the context, then ruling out external factors before diving deep into internal causes. We'll break down the metric, gather relevant data, form hypotheses, and conduct a thorough root cause analysis. Finally, we'll develop a comprehensive plan to validate our findings and implement solutions.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might have been a recent change in the production process. Have there been any modifications to the BioPeroxide manufacturing process in the last 1-2 months?

Why it matters: Process changes could directly impact production costs. Expected answer: Yes, we implemented a new fermentation technique. Impact on approach: If yes, we'd focus on the new process; if no, we'd look at other factors.

• Given the significant increase, I'm wondering about raw material costs. Have there been any notable changes in the prices of key ingredients for BioPeroxide?

Why it matters: Raw material costs are a major component of production expenses. Expected answer: Sugar prices have increased by 15% recently. Impact on approach: If yes, we'd investigate supply chain issues; if no, we'd focus more on internal factors.

• Considering the scale of the increase, I'm curious about production volume. Has there been any significant change in the production volume of BioPeroxide in the last month?

Why it matters: Changes in scale can affect unit costs dramatically. Expected answer: Production volume has remained stable. Impact on approach: If volume changed, we'd look at scaling issues; if not, we'd focus on other cost drivers.

• Given the potential for measurement errors, I'm wondering about our cost tracking systems. Have there been any changes to how we measure or report production costs recently?

Why it matters: Ensures we're comparing apples to apples in our cost analysis. Expected answer: No changes to cost tracking systems. Impact on approach: If yes, we'd need to validate the data; if no, we can trust the reported increase.